New Independent Study Supports Photodisinfection Ondine Biomedical Provides Biological Context for Nasal Decolonization Strategies Following Landmark Nasal Microbiome Study Ondine Biomedical Inc. (AIM: OBI), a leader in light-activated antimicrobial therapies, highlights new biological evidence supporting its photodisinfection technology in a newly published study in Nature Communications (Aggarwal et al., 2025). [...]